Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis... see more

NDAQ:AUPH - Post Discussion

View:
Post by pangloss5 on Feb 18, 2020 8:04pm

Catalysts

Aurinia got the pop I had invested for. But it's held around 25 for a while now, and I think institutional ownership is rising. People on stocktwits were excited about bio investors Baker brothers investing. This is a rare cdn stock that gets more attention south of the border.
Comment by pangloss5 on Feb 18, 2020 8:13pm
... I forgot my point about catalysts. A dry eye possibility has captured attention, but I didnt initially invest on that thesis, so Im neutral on that. Others expect a buyout, which could be true but that's a constant theme on investment boards. I'm holding, might add a few hundred shares, but i would love to hear from others who have a better sense than I do about further upside (or lack ...more  
Comment by KonradvonMarbur on May 22, 2020 6:21pm
I still see this as a high-risk stock. -19 I would potentially buy. Looking to see updated prospectus.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities